RhumbLine Advisers’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
116,521
+1,714
| +1% | +$42.6K | ﹤0.01% | 1678 |
|
|
2025
Q1 | $3.56M | Sell |
114,807
-94
| -0.1% | -$2.92K | ﹤0.01% | 1526 |
|
|
2024
Q4 | $3.62M | Sell |
114,901
-1,049
| -0.9% | -$33.1K | ﹤0.01% | 1583 |
|
|
2024
Q3 | $6.72M | Sell |
115,950
-5,074
| -4% | -$294K | 0.01% | 1264 |
|
|
2024
Q2 | $4.91M | Buy |
121,024
+49
| +0% | +$1.99K | ﹤0.01% | 1415 |
|
|
2024
Q1 | $5.08M | Buy |
120,975
+1,007
| +0.8% | +$42.3K | ﹤0.01% | 1413 |
|
|
2023
Q4 | $4.59M | Sell |
119,968
-8,663
| -7% | -$332K | ﹤0.01% | 1473 |
|
|
2023
Q3 | $3.97M | Buy |
128,631
+3,565
| +3% | +$110K | ﹤0.01% | 1484 |
|
|
2023
Q2 | $3.95M | Buy |
125,066
+5,289
| +4% | +$167K | ﹤0.01% | 1524 |
|
|
2023
Q1 | $4.37M | Buy |
119,777
+5,421
| +5% | +$198K | 0.01% | 1407 |
|
|
2022
Q4 | $3.38M | Buy |
114,356
+8,801
| +8% | +$260K | ﹤0.01% | 1517 |
|
|
2022
Q3 | $4.12M | Buy |
105,555
+5,658
| +6% | +$221K | 0.01% | 1348 |
|
|
2022
Q2 | $3.86M | Buy |
99,897
+7,091
| +8% | +$274K | 0.01% | 1395 |
|
|
2022
Q1 | $4.5M | Buy |
92,806
+6,484
| +8% | +$314K | 0.01% | 1383 |
|
|
2021
Q4 | $6.34M | Sell |
86,322
-1,685
| -2% | -$124K | 0.01% | 1232 |
|
|
2021
Q3 | $8.01M | Buy |
88,007
+28,401
| +48% | +$2.59M | 0.01% | 1079 |
|
|
2021
Q2 | $3.74M | Buy |
59,606
+39,075
| +190% | +$2.45M | ﹤0.01% | 1599 |
|
|
2021
Q1 | $556K | Sell |
20,531
-1,345
| -6% | -$36.4K | ﹤0.01% | 2440 |
|
|
2020
Q4 | $400K | Buy |
21,876
+2,668
| +14% | +$48.8K | ﹤0.01% | 2530 |
|
|
2020
Q3 | $345K | Buy |
19,208
+1,254
| +7% | +$22.5K | ﹤0.01% | 2456 |
|
|
2020
Q2 | $296K | Buy |
17,954
+2,235
| +14% | +$36.8K | ﹤0.01% | 2584 |
|
|
2020
Q1 | $203K | Sell |
15,719
-301
| -2% | -$3.89K | ﹤0.01% | 2576 |
|
|
2019
Q4 | $295K | Sell |
16,020
-13,805
| -46% | -$254K | ﹤0.01% | 2597 |
|
|
2019
Q3 | $526K | Buy |
+29,825
| New | +$526K | ﹤0.01% | 2301 |
|
|
2018
Q3 | – | Sell |
-22,078
| Closed | -$571K | – | 2938 |
|
|
2018
Q2 | $571K | Buy |
+22,078
| New | +$571K | ﹤0.01% | 2244 |
|